Basic Research Open Access
Copyright ©The Author(s) 2002. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 15, 2002; 8(1): 176-179
Published online Feb 15, 2002. doi: 10.3748/wjg.v8.i1.176
Study on of bioadhesive property of carbomer934 by a gamma camera in vivo
Jie Fu, Xun Sun, Zhi-Rong Zhang, West China School of Pharmacy, Sichuan University, Chengdu 610041, China
Author contributions: All authors contributed equally to the work.
Supported by the Nation Distinguished Youth Scientific Fund (No. 39925039)
Correspondence to: Zhi-Rong Zhang, Ph.D., West China School of Pharmacy, Sichuan University. Chengdu, 610041, China. zrzzl@mail.sc.cninfo.net
Telephone: +86-28-5501566 Fax: +86-28-5456898
Received: July 19, 2001
Revised: September 23, 2001
Accepted: October 27, 2001
Published online: February 15, 2002

Abstract

AIM: To study the bioadhesive property of carbomer934 in dog alimentary tract.

METHODS: Carbomer934 and ethylcellulose were radiolabelled with technetium-99 m; and Gastrointestinal emptying rate of materials was measured using the technique of gamma scintigraphy.

RESULTS: After oral administration, the maximum intestinal radioactivity of non-bioadhesive granules and bioadhesive granules were observed in the second hour and the sixth hour respectively. Constants of stomach emptying rate of nonadhesive granules, bioadhesive granulesI and bioadhesive granulesII were 0.774 h-1,0.265 h-1 and 0.321 h-1 respectively on the base of gastric residual amount. Compared to nonadhesive material (ethylcellulose), the migration rate of adhesive material(carbomer934) was remarkably slower in dog alimentary canal.

CONCLUSION: It is concluded that, in the dog, interactions between gastrointestinal mucus layer and adhesive material or nonadhesive material were significantly different. Carbomer934 had stronger in vivo bioadhesive property than ethylcellulose.




INTRODUCTION

A problem frequently encountered with controlled release dosage forms is the inability to increase residence time of the dosage form in the stomach and proximal portion of the small intestine. Under fast condition, gastric residence of a dosage form is typically short, which is not more them an hour and it is also common for dosage forms to transit rapidly through the small intestine for not more than 3 h[1]. Rapid GI transit phenomena may consequently diminish the extent of absorption of many drugs. Since many drug compounds are absorbed exclusively in the small intestine or in a limited segment of the intestine, it would therefore be beneficial to develop sustained release dosage forms, which remain in the stomach for an extended period of time. Several approaches have been tried to prolong gastric residence, one of which is the use of oral bioadhesive formulation[2,3]. A number of charged and neutral polymers have been classified as bio/ mucoadhesives, since they are known to bind very strongly to mucus via non-covalent bonds.[4,5] Carbomer is a polyacrylic acid polymer, crosslinked with allyl sucrose. As a mucoadhesive polymer, carbomer has been investigated extensively by the pharmaceutical researchers because of its high viscosity at low concentration and low toxicity[6-15] In vitro experiment has proved that carbomer934 have good bioadhesion with the gastrointestinal mucus[16-19]. Our research strategy is to investigate the in vivo bioadhesion of carbomer934 through measuring the migration rate of radioactive carbomer934 granules in dog alimentary tract by a gamma camera. Gamma scintigraphy is an elegant imaging technique which allows the intestinal performance of pharmaceutical formulations to be visualized.[20] Over the past 20 years the approach has become the technique of choice for probing the complex interaction of drug preparation/formulations with the heterogeneous environment of the gut[21-29]

MATERIALS AND METHODS
Materials and apparatus

Ethylcelluose200cps (EC, imported from Roth Co. Ltd., obtained from Shanghai Chemical Agents Distributing Factory); Stearic acid(AP, supplied by Shanghai Stock and Accommodate Station of Chemical Agents); Carbomer934 (Cb934, purchased from Shanghai Shenxing Pharmacy Co. Ltd); 99m TcO4(China Institute for A-energy and Isotope); γ-ray camera(Orbiter, Semens Co. Ltd, Germany); and Dog (provided by Laboratory Animal Center, Sicuan University).

Methods

Radiolabeling of Cb934 and ethylcellulose Procedures of Cb934 and ethylcellulose radiolabelled were described in brief as follows: In vacuum bottle, 1 mL of 0.1 mol·L-1 hydrochloric acid containing 1mg SnCl2 and 1mg vitamin C was added to 2 mL of 15 g·L-1 Cb934(or 30 g·L-1EC) of ethanol solution, then with incorporation of Tc 99mO4. The mixture was warmed at 90 °C for 10 min. Radioactivity chemical purity of radiolabelled materials measured by TLC was beyond 95%.

Preparation of radioactive granules According to the materials proportion of granules listed in Table 1, the mixed materials were solved in ethanol and dried in a rotated vaporizing apparatus. The product was crushed, then manually sieved. The collecting fraction have a size range of 20-40 mesh. An amount of the final blend was filled into hard gelatin capsules (size No.0). Each capsule has an activity of about 111 MBq technetium 99 m at the time of administration.

Table 1 Component proportion of radioactive granules.
granulesPercentage/%
ECCb934Stearic acid
Non-bioadhesive10000
Bioadheive I01000
Bioadheive II05050

Measurement of migration rate of granules in dog alimentary tract The study was an open-labeled, three-period, three treatment crossover study in three dogs (15-20 kg). Each subject received the following treatment in a randomized order: Treatment A: control nonbioadhesive granules, 2 × 111 MBq radioactivity following 24 h fast. Treatment B: bioadhesive granulesI, 2 × 111 MBq radioactivity following 24 h fast. Treatment C: bioadhesive granulesII2 × 111 MBq radioactivity following 24 h fast. Percentage of granules in different segments of dog alimentary canal could be determined according to radioactivity by a γ-ray camera.

RESULTS
Migration rate of three kinds of granules

The dog alimentary tract was divided into three segments of stomach, intestine and colon(including colon,rectum and anus). Radioactivity was measured respectively in different segments (Table 2, 3 and 4). The gastric emptying rate of granules containing Cb934 (bioadhesive granules Iand bioadhesive granulesII) was significantly slower than the control non-bioadhesive granules. After 4 h, percentage of non-bioadhesive granules in stomach was only 7.63%, while bioadhesive granulesI 45.92% and bioadhesive granulesII 37.52%. In the sixth hour, percentage of non-bioadhesive granules,bioadhesive granulesI and bioadhesive granulesIIin dog stomach was 0, 23.2% and 15% respectively.

Table 2 Non-bioadhesive granules in alimentary tract of dog (n = 3).
SitesGranules in different segment of alimentary tract(%)
1 h2 h4 h6 h8 h12 h
Stomach83.726.97.6000
Intestine16.373.259.7000
Colon0032.643.210.60
Table 3 Bioadhesive granulesI in alimentary tract of dog (n = 3).
SitesGranules in different segment of alimentary tract(%)
1 h2 h4 h6 h8 h12 h
Stomach10079.645.423.37.50
Intestine20.454.759.755.130.90
Colon00021.861.654.3
Table 4 Bioadhesive granules IIin alimentary tract of dog (n = 3).
SitesGranules in different segment of alimentary tract(%)
1 h2 h4 h6 h8 h12 h
Stomach10067.137.51500
Intestine032.851.657.929.60
Colon0010.929.770.464.8

Non-bioadhesive granules were emptied to intestine in the first hour and the maximum intestinal radioactivity was observed in the second hour, then intestinal radioactivity was completely eliminated in the sixth hour, bioadhesive granulesI and bioadhesive granulesII began to intestine migrated to in the second hour, and the maximum intestinal radioactivity was observed in the sixth hour. Furthermore considerable intestinal radioactivity could been inspected in the eighth hour. Compared with the non-bioadhesive granules, the bioadhesive granules had delayed onset of emptying to intestine and the maximum radioactivity in intestine. This result indicated that bioadhesion of Cb934 granules on the intestinal mucus was stronger than nonbioadhesive granules. In the fourth hour, a considerable non-bioadhesive pellets have entered the colon and were completely discharged out of anus in the eighth hour. Meanwhile, only very small parts of bioadhesive granules migrated into colon, and as long as the twelfth hour a great deal of granules were still in the dog alimentary tract.

Emptying half life of three kinds of granules in dog stomach

Emptying rate of stomach is fit to the first order kinetics[30]. LogVt = LogV0-Kemt/2.303 Vt:Gastric residual amount at the time of t V0: Gastric residual amount at the time of 0 in stomach Kem: Constant of stomach emptying rate.

Constants of stomach emptying rate of nonadhesive granules, bioadhesive granulesI and bioadhesive granulesII can been calculated as 0.774 h-1, 0.265 h-1, 0.321 h-1 respectively on the base of gastric residual amount. According to gastric residual amount of the first three points of time, constant of gastric emptying rate of bioadhesiveIgranules can be calculated as 0.265 h-1, while according to the latter three points of time, constant can be calculated as 0.449 h-1.

Pictures of γ-ray camera

A majority of nonadhesive granules have been emptied into intestine in the second hour (Figure 1B), then reached colon in the fourth hour (Figure 1C) and a great deal collected at anus in the seventh hour (Figure 1D). In the fourth hour, most bioadhesiveIgranules still mustered in the stomach(Figure 2C) and reached colon in the twelfth hour(Figure 2D). In the fifth hour, most bioadhesiveIIgranules were still in the intestine (Figure 3C) and reached colon in the seventh hour.

Figure 1
Figure 1 Radioactivity in alimentary tract of dog swallowing nonadhesive granules. A, B, C, D: radioactivity at 1, 2, 4 and 7 h.
Figure 2
Figure 2 Radioactivity in alimentary tract of dog swallowing bioadhesiveIgranules. A, B, C, D: radioactivity at 1, 2, 4 and 12 h.
Figure 3
Figure 3 Radioactivity in alimentary tract of dog swallowing bioadhesiveIIgranules. A, B, C, D: radioactivity at 1, 2, 4 and 7 h.
DISCUSSION

According to radioactivity measured by a gamma camera, migration rate of granules containing Cb934 was significantly slower than nonbioadhesive granules. It can be concluded that Cb934 has good bioadhesive properties in vivo and is a possible candidate material for oral bioadhesive preparation.

Compared with the rate constant (0.265 h-1 ) at gastric prophase emptying, gastric anaphase emptying rate constant (0.449 h-1) of bioadhesive granulesIbecame larger. This result showed that gastric emptying rate of Cb934 granules became faster as time went along. It can be inferred that Cb934 was excessively hydrated and caused a lubricative effect, which quickened the gastric emptying of granules. This implied that materials, which not only have good bioadhesive properties and but also can maintain gel status to avoid excessive hydrating, should be preferably considered in oral bioadhesive preparation design.

Footnotes

Edited by Ma JY

References
1.  Barara Naisbett, John Woodley. The potential use of tomato lectin for oral drug delivery: 3.Bioadhesion in vivo. Int J Pharm. 1995;114:227-236.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Schnurch A. B, Humenberger C, Vlaenta C, Basic studied on bioadhesive delivery systems for peptide and protein drugs. Int J Pharm. 1998;165:217-225.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 51]  [Cited by in F6Publishing: 51]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
3.  Arangoa MA, Ponchel G, Orecchioni AM, Renedo MJ, Duchêne D, Irache JM. Bioadhesive potential of gliadin nanoparticulate systems. Eur J Pharm Sci. 2000;11:333-341.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 92]  [Cited by in F6Publishing: 83]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
4.  Madsen F, Eberth K, Smart JD. A rheological examination of the mucoadhesive/mucus interaction: the effect of mucoadhesive type and concentration. J Control Release. 1998;50:167-178.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 157]  [Cited by in F6Publishing: 156]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
5.  Eouani C, Piccerelle P, Prinderre P, Bourret E, Joachim J. In-vitro comparative study of buccal mucoadhesive performance of different polymeric films. Eur J Pharm Biopharm. 2001;52:45-55.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 103]  [Cited by in F6Publishing: 101]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
6.  Nakanishi T, Kaiho F, Hayashi M. Improvement of drug release rate from carbopol 934P formulation. Chem Pharm Bull (Tokyo). 1998;46:171-173.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 19]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
7.  Tan YT, Peh KK, Al-Hanba O. Investigation of interpolymer complexation between Carbopol and various grades of polyvinylpyrrolidone and effects on adhesion strength and swelling properties. J Pharm Pharm Sci. 2001;4:7-14.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Nakanishi T, Kaiho F. Hayashi M. Use of sodium salt of Carbopol 934P in oral peptide delivery. Int J Pharm. 1998;171:177-183.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 9]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
9.  Callens C, Adriaens E, Dierckens K, Remon JP. Toxicological evaluation of a bioadhesive nasal powder containing a starch and Carbopol 974 P on rabbit nasal mucosa and slug mucosa. J Control Release. 2001;76:81-91.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 46]  [Cited by in F6Publishing: 45]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
10.  Repka MA, McGinity JW. Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion. J Control Release. 2001;70:341-351.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 77]  [Cited by in F6Publishing: 78]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
11.  Khan GM, Zhu JB. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug. J Control Release. 1999;57:197-203.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 75]  [Cited by in F6Publishing: 77]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
12.  Ozeki T, Yuasa H, Kanaya Y. Controlled release from solid dispersion composed of poly(ethylene oxide)-Carbopol interpolymer complex with various cross-linking degrees of Carbopol. J Control Release. 2000;63:287-295.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 52]  [Cited by in F6Publishing: 52]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
13.  Khan GM, Jiabi Z. Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug. J Control Release. 1998;54:185-190.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 66]  [Cited by in F6Publishing: 66]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
14.  Muramatsu M, Kanada K, Nishida A, Ouchi K, Saito N, Yoshida M, Shimoaka A, Ozeki T, Yuasa H, Kanaya Y. Application of Carbopol to controlled release preparations I. Carbopol as a novel coating material. Int J Pharm. 2000;199:77-83.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 25]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
15.  Senel S, Capan Y, Sargon MF, Giray CB, Hincal AA. Histological and bioadhesion studies on buccal bioadhesive tablets containing a pen-etration enhancer sodium glycodeoxycholate. Int J Pharm. 1998;170:239-245.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 22]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
16.  Bogataj M, Mrhar A, Korosec L. Influence of physicochemical and biological parameters on drug release from microspheres adhered on vesical and intestinal mucosa. Int J Pharm. 1999;177:211-220.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 21]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
17.  Riley RG, Smart JD, Tsibouklis J, Dettmar PW, Hampson F, Davis JA, Kelly G, Wilber WR. An investigation of mucus/polymer rheological synergism using synthesised and characterised poly(acrylic acid)s. Int J Pharm. 2001;217:87-100.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 79]  [Cited by in F6Publishing: 79]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
18.  Hägerström H, Paulsson M, Edsman K. Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method. Eur J Pharm Sci. 2000;9:301-309.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 86]  [Cited by in F6Publishing: 89]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
19.  Dash AK, Gong Z, Miller DW, Huai-Yan H, Laforet J. Development of a rectal nicotine delivery system for the treatment of ulcerative colitis. Int J Pharm. 1999;190:21-34.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 28]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
20.  Connor AL, Wray H, Cottrell J, Wilding IR. A scintigraphic study to investigate the potential for altered gut distribution of loperamide from a loperamide-simethicone formulation in man. Eur J Pharm Sci. 2001;13:369-374.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 14]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
21.  Sangalli ME, Maroni A, Zema L, Busetti C, Giordano F, Gazzaniga A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Control Release. 2001;73:103-110.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 94]  [Cited by in F6Publishing: 96]  [Article Influence: 4.2]  [Reference Citation Analysis (0)]
22.  Digenis GA, Sandefer EP, Page RC, Doll WJ, Gold TB, Darwazeh NB. Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture. Pharm Res. 2000;17:572-582.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Krishnaiah YS, Satyanarayana S, Rama Prasad YV, Narasimha Rao S. Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy human volunteers. J Control Release. 1998;55:245-252.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 111]  [Cited by in F6Publishing: 115]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
24.  Ishibashi T, Pitcairn GR, Yoshino H, Mizobe M, Wilding IR. Scintigraphic evaluation of a new capsule-type colon specific drug delivery system in healthy volunteers. J Pharm Sci. 1998;87:531-535.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 28]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
25.  Billa N, Yuen KH, Khader MA, Omar A. Gamma-scintigraphic study of the gastrointestinal transit and in vivo dissolution of a controlled release diclofenac sodium formulation in xanthan gum matrices. Int J Pharm. 2000;201:109-120.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 37]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
26.  Haruta S, Kawai K, Jinnouchi S, Ogawara KI, Higaki K, Tamura S, Arimori K, Kimura T. Evaluation of absorption kinetics of orally administered theophylline in rats based on gastrointestinal transit monitoring by gamma scintigraphy. J Pharm Sci. 2001;90:464-473.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
27.  Tang GH, Tang XL. [Application of nuclear medicine techniques in drug development]. Yaoxue Xuebao. 2001;36:390-395.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Wilson CG. In-vivo monitoring of dosage forms. J Pharm Pharmacol. 1998;50:383-386.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 14]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
29.  Wilding IR, Coupe AJ, Davis SS. The role of gamma-scintigraphy in oral drug delivery. Adv Drug Deliv Rev. 2001;46:103-124.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 117]  [Cited by in F6Publishing: 118]  [Article Influence: 5.1]  [Reference Citation Analysis (0)]
30.  Liang WQ. Biopharmaceutics and pharmacokinetics. Beijing: Renming Health Press. 2000;134-136.  [PubMed]  [DOI]  [Cited in This Article: ]